![]() |
The Risk of Amphetamines The research below is the beginning of the the disclosure of a long term use of amphetamine drugs. though it is specifically about Adderall., As Vioxx was the beginning of the disclosure of the risks for all Cox-2 inhibitors. Adderall is beginning for Amphetamines. Since all amphetamines are very similar in their chemical structure and clinical effects, I expect to see many similar studies on the other commonly prescribed amphetamines such as Attenade, Concerta, Ritalin, Metadate, Dexedrine and Focalin.
Canada Regulators Order Adderall Withdrawn TORONTO (AP 2/9/05) - Canadian regulators ordered a daily treatment for attention deficit hyperactivity disorder off the market late Wednesday after learning the drug has been linked to 20 sudden deaths and a dozen strokes, including some among children. Additionally, makers of related stimulants used to treat the commonly diagnosed condition have been asked to provide a thorough review of their worldwide safety data, Health Canada said in a release late Wednesday. None of the deaths or strokes associated with Adderall XR were reported in Canada, department spokesman Ryan Baker said. "However, Health Canada has received eight reports of adverse reactions ranging in severity from convulsions to minor skin rash," Baker said. "It's not been determined yet whether these reactions were a result of Adderall XR use." Of the 20 cases of sudden death linked to the drug, 14 were in children. Two of the 12 strokes were suffered by children taking the drug. The adverse reactions were not associated with overdose, misuse or abuse of the drug, the department said. The drug is made by Shire Pharmaceuticals Group PLC, based in Basingstoke, England, and is sold in Canada and the United States. A related immediate-release form of the drug, sold simply as Adderall, is sold in the United States but has not been approved for sale in Canada, where 11,000 patients are prescribed Adderall XR. Canadian officials approved that drug in January 2004. Shire's chief executive, Matthew Emmens, said in a statement late Wednesday that the company "remains confident in the safety and efficacy" of the drug. Emmens said the U.S. Food and Drug Administration had reviewed the same data as Health Canada last year and sought an additional warning in September that the drug should not be prescribed for people with "structural cardiovascular abnormalities." About 700,000 people take Adderall XR in the United States, with about 300,000 more using Adderall, Shire spokesman Matthew Cabrey said Wednesday. Shire reported $140 million in U.S. sales of the drugs in the third quarter of 2004. The FDA said it "does not feel that any immediate changes are warranted in the FDA labeling or approved use of this drug based upon its preliminary understanding of Health Canada's analyses of adverse event reports and FDA's own knowledge and assessment of the reports received by the agency," according to Dow Jones Newswires. Health Canada is asking people taking the drug or parents of children on it to consult their physicians immediately to select alternatives. It is also asking them not to discard unused pills but rather to take them to a pharmacy for safe disposal. People taking related drugs for the management of ADHD should not stop their treatment but could consult their doctors if they have concerns, the department said. In light of the international reports of adverse reactions, the department reviewed the drug's safety data and conducted a preliminary review of safety data for the other related stimulants authorized for treatment of ADHD in Canada. The incidence of serious adverse reactions leading to death was higher in Adderall and Adderall XR combined than in any other drugs of this class, the release said. ADHD is the most commonly diagnosed psychiatric disorder among school-aged children. There is a highly effective treatment alternative to drugs. For over 35 years I have worked with ADHD children and their families. Having been an ADHD child myself, I have a personal interest in this area. Current explanations of the disorder never fit my experience or the children I saw. It always seemed contradictory that children who could not attend to school work could play computer games for hours, though both activities use the same areas of the brain. This stimulated years of research and rethinking of ADHD theory and treatment. From this I developed my new (patented) and highly effective, drug free, Computer Aided Emotional Restructuring (CAER) treatment and wrote my books, ADHD: Drug-free and Doin' Fine and , ADHD: A Path to Success to explain it. Learn how ADHD is not a defect, deficit or a disorder, but a highly skilled short-term defense mechanism that backfires in the long-run. Read more than 40 Amazon.com “customer reviews” of my book and treatment. The most typical response when people read the book is “That makes so much more sense than anything else I have read”, “You describe my child exactly”. It will empower you an optimistic lens that will forever change how you see your child and his problems. Sound intriguing? Learn about it now.
|
|
Anti-Hypertensive |